Outcomes of highly active antiretroviral therapy in the context of universal access to healthcare: the U.S. Military HIV Natural History Study
Vincent C. Marconi(Emory University), Brian K. Agan(Henry M. Jackson Foundation), Nancy F. Crum‐Cianflone(Henry M. Jackson Foundation), Helen Chun, Glenn Wortmann(Walter Reed National Military Medical Center), Robert J. O’Connell(Walter Reed Army Institute of Research), Amy Weintrob, Jason F. Okulicz(Gilead Sciences (United States)), Michael L. Landrum(San Antonio Military Medical Center), Anuradha Ganesan(Walter Reed National Military Medical Center), Alan R. Lifson(University of Minnesota), Greg Grandits
Cited by 83
Related Papers
World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions
|The Lancet Global Health|2019|1.2k
Enhanced CD4+ T-Cell Recovery with Earlier HIV-1 Antiretroviral Therapy
|New England Journal of Medicine|2013|358
Clinical Outcomes of Elite Controllers, Viremic Controllers, and Long‐Term Nonprogressors in the US Department of Defense HIV Natural History Study
|The Journal of Infectious Diseases|2009|305
Invasive Mold Infections Following Combat-related Injuries
|Clinical Infectious Diseases|2012|191
Epidemiology and clinical characteristics of elite controllers
|Current Opinion in HIV and AIDS|2011|176